Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance

NCT01373242 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of North Carolina, Chapel Hill

Collaborators